Aditxt, Inc. Increase (Decrease) in Receivables
Aditxt, Inc. (ADTX) reported Increase (Decrease) in Receivables of $418.43 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2021-11-15
- Aditxt, Inc. increase (decrease) in receivables for the quarter ending 2021-09-30 was $176.99K.
- Aditxt, Inc. increase (decrease) in receivables for the quarter ending 2021-06-30 was $133.34K.
- Aditxt, Inc. increase (decrease) in receivables for the quarter ending 2021-03-31 was $108.11K.
- Aditxt, Inc. increase (decrease) in receivables for fiscal 2020 was $58.48K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2021-09-30 | $176.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $310.32K derived: sum of 2 quarters · filed 2021-11-15 | $418.43K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $133.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $241.44K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $108.11K 10-Q · filed 2021-05-12 | |||
| 2020-12-31 | $58.48K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |